SEARCH

SEARCH BY CITATION

References

  • Altmann, K.H., Fabbro, D., Dean, N.M., Geiger, T., Monia, B.P., Muller, M. & Nicklin, P. (1996) Second-generation antisense oligonucleotides: structure-activity relationships and the design of improved signal-transduction inhibitors. Biochemical Society Transactions, 24, 630637.
  • Boersma, A.W., Nooter, K., Oostrum, R.G. & Stoter, G. (1996) Quantification of apoptotic cells with fluoroscein isothiocyanate-labelled annexin-V in Chinese hamster ovary cell cultures treated with cisplatin. Cytometry, 24, 123130.DOI: 10.1002/(sici)1097-0320(19960601)24:2<123::aid-cyto4>3.3.co;2-8
  • Castedo, M., Hirsch, T., Susin, S.A., Zamzami, N., Marchetti, P., Macho, A. & Kroemer, G. (1996) Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. Journal of Immunology, 157, 512521.
  • Cioffi, C.L., Garay, M., Johnston, J.F., McGraw, K., Boggs, R.T., Hreniuk, D. & Monia, B.P. (1997) Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation. Molecular Pharmacology, 51, 383389.
  • Crooke, S.T. (1996) Proof of mechanism of antisense drugs. Antisense Nucleic Acid Drug Development, 6, 145147.
  • Crooke, S.T. (1998) Molecular mechanisms of antisense drugs: RNase H. Antisense Nucleic Acid Drug Development, 8, 133134.
  • Dean, N.M. & McKay, R. (1994) Inhibition of protein kinase C- alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proceedings of the National Academy of Sciences of the United States of America, 91, 1176211766.
  • Dean, N., McKay, R., Miraglia, L., Howard, R., Cooper, S., Giddings, J., Nicklin, P., Meister, L., Ziel, R., Geiger, T., Muller, M. & Fabbro, D. (1996) Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-alpha expression. Cancer Research, 56, 34993507.
  • Green, D.R. & Reed, J.C. (1998) Mitochondria and apoptosis. Science, 281, 13091312.
  • Ho, S.P., Bao, Y., Lesher, T., Malhotra, R., Ma, L.Y., Fluharty, S.J. & Sakai, R.R. (1998) Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries. Nature Biotechnology, 16, 5963.
  • Joseph Liauzun, E., Farges, R., Delmas, P., Ferrara, P. & Loison, G. (1997) The M(r) 18,000 subunit of the peripheral-type benzodiazepine receptor exhibits both benzodiazepine and isoquinoline carboxamide binding sites in the absence of the voltage-dependent anion channel or of the adenine nucleotide carrier. Journal of Biological Chemistry, 272, 2810228106.
  • Kelekar, A. & Thompson, C.B. (1998) Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends in Cell Biology, 8, 324330.DOI: 10.1016/s0962-8924(98)01321-x
  • Kharbanda, S., Pandey, P., Schofield, L., Israels, S., Roncinske, R., Yoshida, K., Bharti, A., Yuan, Z.M., Saxena, S., Weichselbaum, R., Nalin, C. & Kufe, D. (1997) Role for Bcl-x (L) as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 94, 69396942.
  • Kim, C.N., Wang, X., Huang, Y., Ibrado, A.M., Liu, L., Fang, G. & Bhalla, K. (1997) Overexpression of Bcl-X (L) inhibits Ara-C-induced mitochondrial loss of cytochrome C and other perturbations that activate the molecular cascade of apoptosis. Cancer Research, 57, 31153120.
  • Koopman, G., Reutelingsperger, C.P.M., Kuijten, G.A.M., Keehan, R.M.J., Pals, S.T. & Van Oers, M.H.J. (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apopotosis. Blood, 84, 14151420.
  • Kroemer, G., Dallaporta, B. & Resche Rigon, M. (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annual Review of Physiology, 60, 619642.
  • Lemasters, J.J., Nieminen, A.L., Qian, T., Trost, L.C., Elmore, S.P., Nishimura, Y., Crowe, R.A., Cascio, W.E., Bradham, C.A., Brenner, D.A. & Herman, B. (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochimica et Biophysica Acta Bioenergetics, 2, 177196.
  • Levesque, L., Dean, N.M., Sasmor, H. & Crooke, S.T. (1997) Antisense oligonucleotides targeting human protein kinase C- alpha inhibit phorbol ester-induced reduction of bradykinin-evoked calcium mobilization in A549 cells. Molecular Pharmacology, 51, 209216.
  • Li, P., Nijhawan, D., Budlhardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S. & Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, 479489.
  • Ling, F., Srinivasan, A., Wang, Y., Armstrong, R.C., Tomaselli, K.J. & Fritz, L.C. (1997) Cell-specific induction of apoptosis by microinjection of cytochrome c. Bcl-x(L) has activity independent of cytochrome c release. Journal of Biological Chemistry, 272, 3029930305.
  • Liu, X., Kim, C.N., Yang, J., Jemmerson, R. & Wang, X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 86, 147157.
  • Marzo, I., Brenner, C., Zamzami, N., Susin, S.A., Beutner, G., Brdiczka, D., Remy, R., Xie, Z.H., Reed, J.C. & Kroemer, G. (1998a) The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2-related proteins. Journal of Experimental Medicine, 187, 12611271.
  • Marzo, I., Brenner, C. & Kroemer, G. (1998b) The central role of the mitochondrial megachannel in apoptosis: evidence obtained with intact cells, isolated mitochondria, and purified protein complexes. Biomedicine and Pharmacotherapy, 52, 248251.
  • Marzo, I., Brenner, C., Zamzami, N., Jurgensmeier, J.M., Susin, S.A., Vieira, H.L.A., Prevost, M.C., Xie, Z., Matsuyama, S., Reed, J.C. & Kroemer, G. (1998c) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science, 281, 20272031.
  • Milner, N., Mir, K.U. & Southern, E.M. (1997) Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nature Biotechnology, 15, 537541.
  • Minn, A.J., Velez, P., Schendel, S.L., Liang, H., Muchmore, S.W., Fesik, S.W., Fill, M. & Thompson, C.B. (1997) Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature, 385, 353357.
  • Miyashita, T. & Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293299.
  • Monia, B.P., Lesnik, E.A., Gonzalez, C., Lima, W.F., McGee, D., Guinosso, C.J., Kawasaki, A.M., Cook, P.D. & Freier, S.M. (1993) Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. Journal of Biological Chemistry, 268, 1451414522.
  • Monia, B.P., Johnston, J.F., Geiger, T., Muller, M. & Fabbro, D. (1996) Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nature Medicine, 2, 668675.
  • Nicolli, A., Basso, E., Petronilli, V., Wenger, R.M. & Bernardi, P. (1996) Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, a cyclosporin A-sensitive channel. Journal of Biological Chemistry, 271, 21852192.
  • Oltvai, Z.N., Milliman, C.L. & Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell, 74, 609619.
  • Pastorino, J.G., Chen, S.T., Tafani, M., Snyder, J.W. & Farber, J.L. (1998) The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. Journal of Biological Chemistry, 273, 77707775.
  • Pollman, M.J., Hall, J.L., Mann, M.J., Zhang, L. & Gibbons, G.H. (1998) Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nature Medicine, 4, 222227.
  • Reed, J.C. (1997) Double identity for proteins of the Bcl-2 family. Nature, 387, 773776.DOI: 10.1038/42867
  • Ruck, A., Dolder, M., Wallimann, T. & Brdiczka, D. (1998) Reconstituted adenine nucleotide translocase forms a channel for small molecules comparable to the mitochondrial permeability transition pore. FEBS Letters, 426, 97101.DOI: 10.1016/s0014-5793(98)00317-2
  • Sedlak, T.W., Oltvai, Z.N., Yang, E., Wang, K., Boise, L.H., Thompson, C.B. & Korsmeyer, S.J. (1995) Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proceedings of the National Academy of Sciences of the United States of America, 92, 78347838.
  • Shimizu, S., Eguchi, Y., Kamiike, W., Funahashi, Y., Mignon, A., Lacronique, V., Matsuda, H. & Tsujimoto, Y. (1998) Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proceedings of the National Academy of Sciences of the United States of America, 95, 14551459.
  • Stewart, A.J., Canitrot, Y., Baracchini, E., Dean, N.M., Deeley, R.G. & Cole, S.P. (1996) Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides. Biochemical Pharmacology, 51, 461469.DOI: 10.1016/0006-2952(95)02220-1
  • Susin, S.A., Zamzami, N. & Kroemer, G. (1998) Mitochondria as regulators of apoptosis: doubt no more. Biochimica et Biophysica Acta, 1366, 151165.
  • Szabo, I. & Zoratti, M. (1992) The mitochondrial megachannel is the permeability transition pore. Journal of Bioenergetics and Biomembranes, 24, 111117.
  • Szabo, I. & Zoratti, M. (1993) The mitochondrial permeability transition pore may comprise VDAC molecules. I. Binary structure and voltage dependence of the pore. FEBS Letters, 330, 201205.
  • Szabo, I., De Pinto, V. & Zoratti, M. (1993) The mitochondrial permeability transition pore may comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitochondrial megachannel. FEBS Letters, 330, 206210.
  • Taylor, J.K., Zhang, Q.Q., Monia, B.P., Marcusson, E.G. & Dean, N.M. (1999) Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli. Oncogene, 18, 44954504.
  • Van den Eijnde, S.M., Boshart, L., Reutelingsperger, C.P.M., De Zeeuw, C.I. & Vermeij Keers, C. (1997) Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis. Cell Death and Differentiation, 4, 311316.
  • Van Engeland, M., Nieland, L.J.W., Ramaekers, F.C.S., Schutte, B. & Reutelingsperger, C.P.M. (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry, 31, 19.DOI: 10.1002/(sici)1097-0320(19980101)31:1<1::aid-cyto1>3.0.co;2-r
  • Vermes, I., Haanen, C., Steffens Nakken, H. & Reutelingsperger, C. (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. Journal of Immunological Methods, 184, 3951.DOI: 10.1016/0022-1759(95)00072-i
  • Yang, J.C. & Cortopassi, G.A. (1998) Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome C. Free Radical Biology and Medicine, 24, 624631.DOI: 10.1016/s0891-5849(97)00367-5
  • Yang, E., Zha, J., Jockel, J., Boise, L.H., Thompson, C.B. & Korsmeyer, S.J. (1995) Bad, a heterodimeric partner for Bcl-x(L), and Bcl-2, displaces Bax and promotes cell death. Cell, 80, 285291.
  • Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssiere, J.L., Petit, P.X. & Kroemer, G. (1995) Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. Journal of Experimental Medicine, 181, 16611672.
  • Zamzami, N., Susin, S.A., Marchetti, P., Hirsch, T., Gomez Monterrey, I., Castedo, M. & Kroemer, G. (1996) Mitochondrial control of nuclear apoptosis. Journal of Experimental Medicine, 183, 15331544.
  • Zamzami, N., Brenner, C., Marzo, I., Susin, S.A. & Kroemer, G. (1998) Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene, 16, 22652282.
  • Zou, H., Henzel, W.J., Liu, X., Lutschg, A. & Wang, X. (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 90, 405413.